Geoffrey Beurskens
Partner, Advocaat, The Netherlands
Geoffrey is a Partner in the corporate team who specializes in mergers and acquisitions, venture capital, private equity investments and joint ventures.
He has a particular focus on the Tech, Media and Comms and Life Science & Healthcare and Financial Services sectors with experience acting for a wide range of clients. Geoffrey also has broad experience with assisting start-up companies on both commercial, corporate law matters and financing rounds.
Geoffrey joined Osborne Clarke in 2016 from international law firm Bird & Bird. He successfully completed the post-graduate course National and International Contracts at the Grotius Academy in 2015.
Geoffrey Beurskens is knowledgeable, experienced, pragmatic, flexible and a pleasure to work with. Solution-oriented.
DSM Venturing
Advised DSM Venturing on the $47 million Series A funding round in innovative food company, Meatable. Read more >
Wildstone
Advised the UK group Wildstone on the acquisition of the Spanish group of outdoor advertising Redext.
EQT Ventures
Advised EQT Ventures with the investment in Siilo, a secure mobile messaging service bringing medical teams together.
ViroClinics
Represented Gilde Healthcare and key management (sellers) in the auction sale of ViroClinics Biosciences B.V. to Parcom Capital, a leading mid-market private equity firm in the Benelux, as well key management in their continuing investment in ViroClinics post-closing.
Bioclin Therapeutics
Represented new investors INKEF Capital and Sectoral Asset Management as well as existing investors Sofinnova Ventures and Ysios Capital in respect of the USD 50 million Series B financing round of BioClin Therapeutics. Other investors include HealthCap, Tekla Capital Management funds and Life Sciences Partners (LSP). Read more
Lava Therapeutics
Advised a syndicate of investors led by Gilde Healthcare and Versant Ventures with additional support from US-based MRL Ventures Fund in the EUR 16 million financing round of Lava Therapeutics, read more
Calco Group
Assisted shareholders with the sale to Inflexion Private Equity of Calco Group B.V. (“Calco”), a leading Dutch provider of IT recruitment and training services and specialised in staffing of junior IT personnel to large blue-chip corporates, operating primarily within the finance and insurance sectors with clients including the main banks and the top insurance companies in the Netherlands.
A-Gas
Advised A-Gas on the acquisition of Netherlands' reclamation business BTC.
Breath Therapeutics
Represented Breath Therapeutics on EUR 43.5m Series A financing round by Gimv, Sofinnova Partners and Gilde Healthcare.
Sofinnova Ventures & Ysios Capital
Represented Sofinnova Ventures and Ysios Capital as lead investors in the USD 30 million Series B Financing round of BioClin Therapeutics.
Atradius Insurance Holding N.V.
Osborne Clarke has advised Atradius Insurance Holding N.V. on its sale of Graydon Holding N.V. to Creditsafe Nederland BV.
Vaultier7 LLP
Osborne Clarke has advised Vaultier7 LLP (existing investor) in relation to a minority equity investment by Eurazeo (new investor) in Gisou, a high-growth premium haircare brand offering an authentic bee-based approach to beauty.
Contact
Geoffrey
Insights
Corporate
Doing deals: A Dutch view of pitfalls in the current global economic climate
The current economic climate requires a careful and tailored approach to M&A in order to get your deal done
06/04/2023
Corporate
Action required from employers to take advantage of amendment of the Dutch share option regime
The Dutch share option regime has changed in order to attract more talent to start-ups – as of 1 January...
03/04/2023
